DGAP-News: MediClin AG / Key word(s): 9-month figures/9-month figures MediClin AG: Group sales and Group operting result increased - Earnings forecast for the 2014 financial year has been slightly raised 31.10.2014 / 14:30 --------------------------------------------------------------------- MediClin: Group sales and Group operting result increased - Earnings forecast for the 2014 financial year has been slightly raised Offenburg, October 31, 2014 - In the first nine months of 2014 MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 402.8 mill. (9M 2013: EUR 389.7 mill.) thus being EUR 13.1 mill. or 3.4 % above the previous year's value. The post-acute segment contributed EUR 11.1 mill. and the acute segment EUR 2.3 mill. to the sales increase. The occupancy rate of the Group improved to 87.6 % (9M 2013: 85.4 %). Compared to the nine-month-period 2013 the Group operating result improved by EUR 10.0 mill. from EUR 2.2 mill. to EUR 12.2 mill. and the result after tax attributable to shareholders of MediClin AG by EUR 9.4 mill. from EUR -1.4 mill. to EUR 8.0 mill. Decisive for the good development in the Group was the continuing positive sales and earnings development of the post-acute segment in the 3rd quarter compared with the previous year as well as with the 1st and 2nd quarter 2014 so that in the 3rd quarter a Group operating result of EUR 9.1 mill. could be achieved. Particularly well performed the clinics of the post-acute segment which offer besides rehabilitation services also services of acute-neurology and acute-psychosomatic - the focus of investments was set on this expansion in 2012 and 2013. In the acute segment the segment result amounted to EUR 6.7 mill., which was EUR 0.7 mill. above the previous year's value. As of September 30, 2014 cash and cash equivalents were EUR 24.6 mill. (30.09.2013: EUR 16.3 mill.). In the first nine months of 2014 EUR 14.2 mill. (gross) was invested in non-current assets, thus being EUR 0.8 mill. above previous year's level. The equity ratio was 47.9 % (30.09.2013: 48.6 %). In the first nine months of 2014 MediClin employed on average 6,405 employees, measured in full-time employees (9M 2013: 6,372 full-time employees). Sales forecast for the 2014 financial year is confirmed - earnings forecast has been slightly raised The business development of the first nine months 2014 leads to the expectation that the predicted sales targets of the Group (+3.0 %) and of the segments post-acute (+4.5 % to +5.0 %) and acute (+1.0 % to +1.5%) will be achieved. The earning targets of EUR 4 to 6 mill. for the Group operating result will be slightly increased. The interim report as of September 30, 2014 will be available in German and English from November 10, 2014 under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 10 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,800 employees. MediClin â a company of the Asklepios Group --------------------------------------------------------------------- 31.10.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG OkenstraÃe 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: alexandra.muehr@mediclin.de Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 294427 31.10.2014
DGAP-News: MediClin AG: Group sales and Group operting
Top 10 Most Recent News Articles
Insider Risk Makes Human Judgment a Security Priority
A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...
Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D
Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...
Continue Reading
Veterans United Foundation Marks 15 Years of Giving
A Milestone Measured in More Than Checks Fifteen years can turn a workplace charity into background noise, but this one plainly has not drifted into autopilot. Veterans United Foundation closed its 2026 anniversary campaign, called The Good Goes On, with $1.5 million directed to charitable organizations, 1,145 employee volunteers, and 2,680 hours of hands-on work. That is...
Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables
A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...
Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win
Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...
Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind
A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...
Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal
Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...
Continue Reading
Racura's AML Trial Clears Its First Crucial Hurdle
One signature from Sheba does not cure leukemia, but it does move Racura Oncology from talking about EMILI to doing the hard, expensive work of enrolling patients. For a company at this stage, that distinction matters. Ethics approval for the seamless Phase 2b/3 RC220 study in relapsed or refractory acute myeloid leukemia is a real operational milestone, not the sort of...
Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move
Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...
Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context
Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...
Continue ReadingTop 5 Most Recently Viewed Articles
UP Oncolytics Boosts Funding to Propel Brain Cancer Research
UP Oncolytics Secures Significant Grant for Research Advancement UP Oncolytics, a pioneering biotechnology company specializing in neuro-oncology, is making headlines with its latest achievement in funding. This innovative company, a spin-out from a prominent research institution, has secured a matching grant to further its mission in developing oncolytic virus therapy...
Continue Reading
US Dollar Weakness Fuels Gold's Safe Haven Appeal Amid Trade Tensions
US Dollar Weakness Benefits Gold Amid Trade Concerns The US dollar has been retreating against several major currencies, largely influenced by recent dovish comments from Fed Governor Waller. The anticipation of further developments in trade negotiations is another factor keeping investors on edge as they navigate these financial currents. Fed’s Influence on the Dollar...
Continue Reading
Tesla's Strategic Partnerships with Local Suppliers in China
Tesla's Strategic Partnerships with Local Suppliers in China Tesla, Inc. (NASDAQ: TSLA) is taking significant steps to enhance its operational efficiency and local presence in the world's largest automotive market, China. Recently reported developments indicate that the iconic electric vehicle manufacturer has successfully established partnerships with over 400 local...
Continue Reading
Collect a Unique Piece of History: Trump Bobblehead Release
Royal Bobbles Launches Limited Edition Bobblehead of President-Elect Trump Add an Iconic Piece of Presidential Inauguration History with a One-of-a-Kind President-Elect Donald J. Trump Bobblehead A Historic Collectible Honoring Strength and Patriotism Royal Bobbles, recognized as the original bobblehead maker, has made an exciting announcement. They are launching the 2025...
Continue Reading
Extant Capital's New $200 Million Investment Marks Growth Path
Extant Capital Receives Significant Investment Boost Extant Capital, an alternative asset management firm, has made an exciting announcement regarding a substantial new investment. The firm has successfully secured a $200 million cornerstone investment from New Holland Capital, marking a pivotal moment in its growth journey. This strategic partnership is set to enhance...
Continue Reading